94 studies found for:    cancer | butyrate
Show Display Options
RSS Create an RSS feed from your search for:
cancer | butyrate
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus
Conditions: Leukemia;   Lymphoma;   Precancerous Condition;   Small Intestine Cancer
Interventions: Drug: arginine butyrate;   Drug: ganciclovir
2 Terminated Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
Conditions: EBV Lymphomas;   Lympho-proliferative Diseases
Interventions: Drug: Arginine Butyrate;   Drug: Ganciclovir;   Drug: Valganciclovir
3 Terminated Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders
Conditions: Lymphoid Malignancies;   Lymphoproliferative Disorders
Interventions: Drug: HQK-1004;   Drug: Valganciclovir (may substitute with ganciclovir)
4 Completed
Has Results
A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients
Conditions: Hypertension;   Brain Tumor;   Epilepsy
Intervention: Drug: Clevidipine
5 Active, not recruiting
Has Results
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Conditions: Brenner Tumor;   Fallopian Tube Cancer;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mixed Epithelial Carcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Ovarian Undifferentiated Adenocarcinoma;   Primary Peritoneal Cavity Cancer;   Stage III Ovarian Epithelial Cancer;   Stage IV Ovarian Epithelial Cancer
Interventions: Other: hydrocortisone/placebo;   Drug: paclitaxel;   Drug: carboplatin;   Biological: bevacizumab
6 Suspended Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Conditions: Adenocarcinoma of the Lung;   Adenosquamous Cell Lung Cancer;   Bronchoalveolar Cell Lung Cancer;   Large Cell Lung Cancer;   Squamous Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer
Interventions: Drug: veliparib;   Other: hydrocortisone/placebo;   Drug: carboplatin;   Drug: paclitaxel;   Radiation: 3-dimensional conformal radiation therapy
7 Terminated Saracatinib in Treating Patients With Prostate Cancer
Conditions: Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: saracatinib;   Other: hydrocortisone/placebo
8 Active, not recruiting Combination Chemotherapy With or Without GDC-0449 in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Adenocarcinoma of the Stomach;   Recurrent Gastric Cancer;   Stage III Gastric Cancer;   Stage IV Gastric Cancer
Interventions: Drug: FOLFOX regimen;   Drug: vismodegib;   Other: hydrocortisone/placebo;   Drug: oxaliplatin;   Drug: leucovorin calcium;   Drug: fluorouracil;   Other: flow cytometry;   Other: enzyme-linked immunosorbent assay;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: laboratory biomarker analysis
9 Recruiting Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
Conditions: Colorectal Cancer;   Head and Neck Cancer
Interventions: Drug: Doxycycline;   Drug: Hydrocortisone 1% cream;   Other: Sunscreen;   Other: Moisturizer;   Drug: Clindamycin;   Drug: Medrol-dose pack (Steroid)
10 Active, not recruiting Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
Conditions: Cervical Cancer;   Cervical Intraepithelial Neoplasia Grade 2;   Cervical Intraepithelial Neoplasia Grade 3
Interventions: Other: hydrocortisone/placebo;   Drug: celecoxib
11 Active, not recruiting Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
Conditions: Adenocarcinoma of the Pancreas;   Recurrent Pancreatic Cancer;   Stage IV Pancreatic Cancer
Interventions: Drug: vismodegib;   Drug: gemcitabine hydrochloride;   Other: hydrocortisone/placebo
12 Active, not recruiting Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ketoconazole;   Drug: hydrocortisone;   Drug: dutasteride;   Drug: lapatinib
13 Recruiting Calcitriol, Ketoconazole, and Hydrocortisone in Treating Patients With Advanced or Recurrent Prostate Cancer
Condition: Prostate Cancer
Interventions: Dietary Supplement: calcitriol;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
14 Terminated A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: aminoglutethimide;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
15 Completed Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: suramin;   Drug: therapeutic hydrocortisone;   Procedure: orchiectomy
16 Unknown  Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Condition: Prostate Cancer
Interventions: Drug: ketoconazole;   Drug: lenalidomide;   Drug: therapeutic hydrocortisone
17 Completed Trilostane for Androgen-Independent Prostate Cancer
Conditions: Prostate Cancer;   Prostate Adenocarcinoma
Interventions: Drug: Trilostane;   Drug: Hydrocortisone
18 Completed Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ketoconazole;   Drug: therapeutic hydrocortisone;   Other: Withdrawal of antiandrogen therapy
19 Completed Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: docetaxel;   Drug: estramustine phosphate sodium;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone
20 Withdrawn Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy
Condition: Prostate Cancer
Interventions: Drug: dexamethasone;   Drug: ketoconazole;   Drug: therapeutic hydrocortisone;   Procedure: pharmacological study

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years